The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Is The Market Value Of The Insulin Delivery Devices Market Projected To Expand During 2026–2030?
The insulin delivery devices market has seen significant expansion in recent years. It is forecast to grow from $19.07 billion in 2025 to $20.61 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.1%. The market’s historical growth can be attributed to factors such as the increasing incidence of diabetes, heightened understanding of diabetes management, the broader availability of insulin treatments, expanded access to healthcare, and a surge in the practice of self-injection.
The insulin delivery devices market size is projected for substantial expansion over the upcoming years. This market is anticipated to reach $28.03 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.0%. The expansion during the forecast period can be linked to an escalating global diabetic population, a heightened need for convenient insulin delivery methods, a strengthening focus on long-term diabetes management, broader access to diabetes care in emerging markets, and the increasing adoption of home healthcare solutions. Prominent trends expected in this period include a rising preference for insulin pens over traditional syringes, an increasing demand for insulin pumps for continuous insulin delivery, a growing inclination towards user-friendly and portable insulin devices, the spread of home-based diabetes management solutions, and an expanding use of disposable and pre-filled insulin delivery devices.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18642&type=smp
What Core Drivers Are Transforming The Insulin Delivery Devices Market?
The increasing occurrence of diabetes is anticipated to fuel the expansion of the insulin delivery devices market in the future. This chronic illness is characterized by elevated blood sugar levels, resulting from either insufficient insulin production by the pancreas or the body’s impaired ability to utilize insulin effectively. Globally, the rise in diabetes rates is largely attributed to sedentary lifestyles, unhealthy dietary habits, and escalating obesity. Insulin delivery devices are vital for managing diabetes, enabling individuals to control their blood sugar levels efficiently through convenient and controlled insulin administration, thereby preventing adverse health outcomes and promoting better health. For example, the International Diabetes Federation, a Belgium-based non-governmental organization, reported that in 2024, approximately 589 million adults aged 20–79 worldwide are living with diabetes. This figure is projected to reach 853 million by 2050. Hence, the increasing prevalence of diabetes is a significant impetus for the growth of the insulin delivery devices market.
How Is Segment Classification Applied In The Insulin Delivery Devices Market?
The insulin delivery devices market covered in this report is segmented –
1) By Type: Insulin Syringes, Insulin Jet Injectors, Pen Needles, Reusable Insulin Pens, Disposable Insulin Pens
2) By Disease Indication: Type 1, Type 2
3) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics Or Centers
Subsegments:
1) By Insulin Syringes: Standard Insulin Syringes, Insulin Syringes With Fixed Or Adjustable Needle Length
2) By Insulin Jet Injectors: Needle-Free Insulin Jet Injectors, High-Pressure Insulin Jet Injectors
3) By Pen Needles: Short Pen Needles, Long Pen Needles
4) By Reusable Insulin Pens: Reusable Pens With Replaceable Cartridges, Refillable Insulin Pens
5) By Disposable Insulin Pens: Single-Use Disposable Insulin Pens, Pre-Filled Disposable Insulin Pens
What Trends Are Affecting The Insulin Delivery Devices Market Dynamics?
Leading firms in the insulin delivery devices market are creating novel products, like insulin pumps, to facilitate either continuous or personalized insulin administration. These programmable medical devices administer insulin constantly or on demand through a catheter inserted beneath the skin. As an illustration, in May 2023, Beta Bionics, a US-based medical technology company, received U.S. Food and Drug Administration approval for its iLet ACE Pump and iLet Dosing Decision Software. The iLet Bionic Pancreas system is intended for individuals aged six and older with type 1 diabetes, integrating two devices with a compatible FDA-cleared integrated continuous glucose monitor (iCGM). This system functions via an automated insulin dosing (AID) mechanism powered by an adaptive closed-loop algorithm, which initially requires only the user’s body weight for setup and removes the necessity for additional insulin dosing parameters. In contrast to traditional pump therapy, this system does not demand manual adjustment of settings, thus simplifying its initiation and management. Furthermore, the iLet device incorporates a meal announcement feature that streamlines mealtime insulin dosing by classifying meals as small, medium, or large, with the algorithm continuously learning and adapting to individual insulin requirements.
Which Organizations Are Operating Within The Insulin Delivery Devices Market?
Major companies operating in the insulin delivery devices market are Novo Nordisk A/S, Medtronic Plc, Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Becton Dickinson and Company, Sanofi SA, Eli Lilly and Company, Abbott Laboratories, EOFlow Co. Ltd., Beta Bionics Inc., Bigfoot Biomedical Inc., CeQur Corporation, Emperra GmbH, Debiotech SA, AMF Medical SA, Aerami Therapeutics Inc., Andain Inc., Apex Medical Devices, Animas Corporation
Access The Complete Insulin Delivery Devices Market Report:
https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report
Which Region Has The Strongest Presence In The Insulin Delivery Devices Market?
North America was the largest region in the insulin delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Insulin Delivery Devices Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report
Browse Through More Reports Similar to the Global Insulin Delivery Devices Market 2026, By The Business Research Company
Wearable Ai Market Report 2026
https://www.thebusinessresearchcompany.com/report/wearable-ai-global-market-report
Smart Wearables Market Report 2026
https://www.thebusinessresearchcompany.com/report/smart-wearables-global-market-report
Wearable Computing Market Report 2026
https://www.thebusinessresearchcompany.com/report/wearable-computing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model